{"id":"https://openalex.org/W2170249603","doi":null,"title":"Recent Progress in the Management of Gouty Arthritis and Hyperuricemia","display_name":"Recent Progress in the Management of Gouty Arthritis and Hyperuricemia","publication_year":2011,"publication_date":"2011-03-01","ids":{"openalex":"https://openalex.org/W2170249603","mag":"2170249603"},"language":"en","primary_location":{"id":"mag:2170249603","doi":null,"is_oa":true,"landing_page_url":"https://e-sciencecentral.org/articles/SC000008380","pdf_url":null,"source":{"id":"https://openalex.org/S162267923","display_name":"The Korean Journal of Internal Medicine","issn_l":"1226-3303","issn":["1226-3303","2005-6648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","kci-registered","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320408","host_organization_name":"Korean Association of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310320408"],"host_organization_lineage_names":["Korean Association of Internal Medicine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Korean Journal of Internal Medicine","raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://e-sciencecentral.org/articles/SC000008380","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100731806","display_name":"Won Park","orcid":"https://orcid.org/0000-0002-0004-8034","observed_orcids":["https://orcid.org/0000-0002-0004-8034"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Won Park","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0004-8034","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5100731806"],"corresponding_institution_ids":[],"apc_list":{"value":500,"currency":"USD","value_usd":500},"apc_paid":{"value":500,"currency":"USD","value_usd":500},"fwci":0.2434,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.66142603,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"80","issue":"3","first_page":"260","last_page":"268"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gout","display_name":"gout","score":0.9179999828338623},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gout-management","display_name":"gout treatment","score":0.7229999899864197},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.9309999942779541},{"id":"https://openalex.org/keywords/xanthine-oxidase-inhibitors","display_name":"xanthine oxidase inhibitors","score":0.8759999871253967},{"id":"https://openalex.org/keywords/febuxostat","display_name":"febuxostat","score":0.9890000224113464},{"id":"https://openalex.org/keywords/pegloticase","display_name":"pegloticase","score":0.9279999732971191},{"id":"https://openalex.org/keywords/uricosuric-agents","display_name":"uricosuric agents","score":0.9779999852180481},{"id":"https://openalex.org/keywords/acute-gout-attack","display_name":"acute gout attack","score":0.7720000147819519},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7919999957084656},{"id":"https://openalex.org/keywords/renal-disease-risk","display_name":"renal disease risk","score":0.6269999742507935},{"id":"https://openalex.org/keywords/hypertension-risk","display_name":"hypertension risk","score":0.4519999921321869},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.5339999794960022},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9614078998565674},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.9519312381744385},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.9062180519104004},{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.8908116221427917},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.704834520816803},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5262086987495422},{"id":"https://openalex.org/C2778102346","wikidata":"https://www.wikidata.org/wiki/Q412509","display_name":"Xanthine oxidase","level":3,"score":0.4458919167518616},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43162256479263306},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4122934937477112},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.35973748564720154},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.33714622259140015},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.08415636420249939},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2170249603","doi":null,"is_oa":true,"landing_page_url":"https://e-sciencecentral.org/articles/SC000008380","pdf_url":null,"source":{"id":"https://openalex.org/S162267923","display_name":"The Korean Journal of Internal Medicine","issn_l":"1226-3303","issn":["1226-3303","2005-6648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","kci-registered","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320408","host_organization_name":"Korean Association of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310320408"],"host_organization_lineage_names":["Korean Association of Internal Medicine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Korean Journal of Internal Medicine","raw_type":null}],"best_oa_location":{"id":"mag:2170249603","doi":null,"is_oa":true,"landing_page_url":"https://e-sciencecentral.org/articles/SC000008380","pdf_url":null,"source":{"id":"https://openalex.org/S162267923","display_name":"The Korean Journal of Internal Medicine","issn_l":"1226-3303","issn":["1226-3303","2005-6648"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","kci-registered","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320408","host_organization_name":"Korean Association of Internal Medicine","host_organization_lineage":["https://openalex.org/P4310320408"],"host_organization_lineage_names":["Korean Association of Internal Medicine"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":null,"is_accepted":false,"is_published":false,"raw_source_name":"The Korean Journal of Internal Medicine","raw_type":null},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W35483300","https://openalex.org/W1534146221","https://openalex.org/W1818105272","https://openalex.org/W1891136938","https://openalex.org/W2000166571","https://openalex.org/W2002915215","https://openalex.org/W2009800174","https://openalex.org/W2015503013","https://openalex.org/W2021110479","https://openalex.org/W2023684970","https://openalex.org/W2025764018","https://openalex.org/W2030062071","https://openalex.org/W2036508585","https://openalex.org/W2057825705","https://openalex.org/W2071823619","https://openalex.org/W2075505106","https://openalex.org/W2083508836","https://openalex.org/W2084187644","https://openalex.org/W2089960745","https://openalex.org/W2098144815","https://openalex.org/W2100379211","https://openalex.org/W2100964858","https://openalex.org/W2106983312","https://openalex.org/W2109581831","https://openalex.org/W2119535728","https://openalex.org/W2124881269","https://openalex.org/W2133915381","https://openalex.org/W2136052345","https://openalex.org/W2151809600","https://openalex.org/W2201766790"],"related_works":["https://openalex.org/W2025764018","https://openalex.org/W2185490382","https://openalex.org/W2346368478","https://openalex.org/W4229000524","https://openalex.org/W1992782747","https://openalex.org/W2042468560","https://openalex.org/W3125591798","https://openalex.org/W2088792463","https://openalex.org/W2018125654","https://openalex.org/W2121633261"],"abstract_inverted_index":{"There":[0,42],"is":[1,11,15,21,29,61,88,131,148,218,224,251,257,263],"an":[2],"increasing":[3],"incidence":[4],"of":[5,31,40,50,55,68,73,86,122,157,189,213,239],"gout":[6,56,94,129,146,194,203,244,276],"and":[7,23,53,57,75,109,117,120,138,159,211,233,266],"hyperuricemia":[8,87,98,126,158,240],"worldwide.":[9],"It":[10,223],"because":[12,90],"the":[13,32,48,65,69,93,97,128,135,140,144,190,199,230,237,258,271,275],"population":[14],"getting":[16],"older,":[17],"their":[18],"life":[19],"style":[20],"sedentary,":[22],"they":[24],"take":[25],"protein-enriched":[26],"food.":[27],"Gout":[28,112],"one":[30],"most":[33,193],"common":[34],"but":[35,95,173,198],"best":[36],"controllable":[37],"chronic":[38,171],"diseases":[39],"adult.":[41],"have":[43,185],"been":[44],"recent":[45],"advances":[46],"in":[47,127,180,192,241],"understanding":[49],"underlying":[51],"mechanisms":[52],"treatment":[54,156,169,238],"hyperuricemia.":[58],"This":[59],"article":[60],"aimed":[62],"to":[63,77,100,208,278],"provide":[64],"practical":[66],"review":[67],"currently":[70],"recommended":[71],"practice":[72],"care":[74],"also":[76,96,177],"introduce":[78],"some":[79,181],"recently":[80,268],"approved":[81,228,269],"drugs.":[82],"The":[83],"management":[84],"concept":[85],"changing":[89],"not":[91,252],"only":[92],"appear":[99],"be":[101,152,178,247],"independent":[102],"risk":[103,161,212],"factors":[104],"for":[105,170,236,274],"hypertension,":[106],"renal":[107],"disease":[108,191],"cardiovascular":[110],"disease.":[111],"causes":[113],"a":[114,167,219,225],"significant":[115],"individual":[116],"social":[118],"burden":[119],"loss":[121],"working":[123],"force.":[124],"Still":[125],"patient":[130],"often":[132,204],"under-treated":[133],"by":[134,139,229,270],"patients":[136,150,195,201,242],"themselves":[137],"physicians":[141],"also.":[142],"Once":[143],"acute":[145],"attack":[147],"controlled,":[149],"should":[151],"followed":[153],"with":[154,202,243],"goal-oriented":[155],"other":[160],"factors.":[162],"Allopurinol":[163],"has":[164],"remained":[165],"as":[166],"first-line":[168],"hyperuricemia,":[172],"uricosuric":[174],"agents":[175],"may":[176,246],"considered":[179],"patients.":[182],"These":[183],"drugs":[184],"provided":[186],"good":[187],"control":[188],"until":[196],"now":[197],"elderly":[200],"carry":[205],"co-medications,":[206],"contra-indication":[207],"these":[209],"drugs,":[210],"adverse":[214],"drug":[215],"reaction.":[216],"Febuxostat":[217],"nonpurine":[220],"xanthine-oxidase":[221],"inhibitor.":[222],"new":[226],"agent":[227],"US":[231,272],"FDA":[232,235,273],"Korean":[234],"which":[245,262],"used":[248],"when":[249],"allopurinol":[250],"tolerated":[253],"or":[254],"contraindicated.":[255],"Pegloticase":[256],"PEGylated":[259],"urate":[260],"oxidase":[261],"very":[264],"potent":[265],"so":[267],"refractory":[277],"conventional":[279],"treatment.":[280],"(Korean":[281],"J":[282],"Med":[283],"2011;80:260-268)":[284]},"counts_by_year":[{"year":2015,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}